Management of Hyperosmolar Hyperglycemic State (HHS) and Diabetic Ketoacidosis (DKA)
For HHS and DKA management, prioritize aggressive fluid resuscitation with isotonic saline (15-20 mL/kg/hour initially), followed by continuous IV insulin at 0.1 units/kg/hour (with a 0.15 units/kg bolus for DKA but NOT for HHS), meticulous potassium replacement to maintain levels of 4-5 mEq/L, and careful monitoring to prevent cerebral edema—particularly avoiding osmolality reduction exceeding 3 mOsm/kg/H₂O per hour. 1, 2
Diagnostic Criteria
DKA Diagnosis
- Blood glucose >250 mg/dL, venous pH <7.3, serum bicarbonate <15 mEq/L, and moderate ketonuria or ketonemia with anion gap >10-12 mEq/L 1, 2
- Severity classification: mild (pH 7.25-7.30, HCO₃ 15-18 mEq/L), moderate (pH 7.00-7.24, HCO₃ 10-15 mEq/L), severe (pH <7.00, HCO₃ <10 mEq/L) 1
- Measure β-hydroxybutyrate directly in blood, NOT urine ketones—the nitroprusside method only detects acetoacetate and acetone, missing the predominant ketoacid β-hydroxybutyrate, and paradoxically worsens during treatment as β-hydroxybutyrate converts to acetoacetate 3, 1
HHS Diagnosis
- Blood glucose ≥600 mg/dL, arterial pH ≥7.30, serum bicarbonate ≥15 mEq/L, minimal ketonuria, and effective serum osmolality ≥320 mOsm/kg H₂O 4, 2
- Calculate effective osmolality: 2[measured Na (mEq/L)] + glucose (mg/dL)/18 3, 4
- Correct serum sodium for hyperglycemia: add 1.6 mEq/L for every 100 mg/dL glucose above 100 mg/dL 3, 4
- Mental status changes are common but NOT mandatory for diagnosis—patients meeting metabolic criteria warrant HHS management regardless of alertness 4
Initial Laboratory Workup
- Obtain immediately: plasma glucose, venous blood gases (arterial unnecessary after initial diagnosis), complete metabolic panel with calculated anion gap, serum osmolality, β-hydroxybutyrate, complete blood count, urinalysis, electrocardiogram, and HbA1c 1, 4
- Consider bacterial cultures (blood, urine, throat) and chest X-ray if infection suspected as precipitating factor 1, 4
Fluid Resuscitation
Initial Fluid Management
- Begin with isotonic saline (0.9% NaCl) at 15-20 mL/kg/hour during the first hour (approximately 1-1.5 L in average adult) to restore circulatory volume and tissue perfusion 1, 2
- Total estimated fluid deficit: approximately 6 liters for DKA, 9 liters for HHS 2
- Critical pitfall: The induced change in serum osmolality must NOT exceed 3 mOsm/kg/H₂O per hour to prevent cerebral edema 3
Subsequent Fluid Therapy
- After initial resuscitation, fluid choice depends on corrected serum sodium: use 0.45% NaCl if corrected sodium is normal or elevated, continue 0.9% NaCl if corrected sodium is low 3
- Switch to 5% dextrose with 0.45-0.75% NaCl when glucose reaches 250 mg/dL in DKA or 250-300 mg/dL in HHS while continuing insulin to clear ketones 3, 2
- In HHS specifically, maintain glucose at 250-300 mg/dL until hyperosmolarity and mental status improve and patient becomes clinically stable 3
Special Populations
- Pediatric patients (<20 years): Initial fluid is 0.9% NaCl at 10-20 mL/kg/hour for first hour, not exceeding 50 mL/kg over first 4 hours 3
- Continue at 1.5 times 24-hour maintenance requirements (approximately 5 mL/kg/hour) to achieve smooth rehydration over 48 hours 3
- Patients with renal or cardiac compromise: Require frequent assessment of cardiac, renal, and mental status during fluid resuscitation to avoid iatrogenic fluid overload 3
Insulin Therapy
DKA Insulin Protocol
- Once hypokalemia (K⁺ <3.3 mEq/L) is excluded, give IV bolus of regular insulin at 0.15 units/kg, followed by continuous infusion at 0.1 unit/kg/hour (5-7 units/hour in adults) 3, 1
- Target glucose decline of 50-75 mg/dL per hour 3, 1
- If glucose does not fall by 50 mg/dL in first hour, double insulin infusion rate hourly until steady decline achieved 3, 1
HHS Insulin Protocol—Critical Difference
- Do NOT give initial insulin bolus in HHS—start continuous infusion at 0.1 unit/kg/hour only after fluid resuscitation has begun 5, 6
- In HHS, glucose decline should initially be managed by fluid resuscitation alone before insulin administration 6
Pediatric Insulin Protocol
- No initial insulin bolus recommended—start continuous infusion at 0.1 unit/kg/hour 3
Transition to Subcutaneous Insulin
- Continue IV insulin until DKA resolves: glucose <200 mg/dL, bicarbonate ≥18 mEq/L, venous pH >7.3, and anion gap ≤12 mEq/L 1, 2
- Administer basal subcutaneous insulin 2-4 hours BEFORE stopping IV insulin to prevent rebound hyperglycemia 1, 2
- Ketonemia takes longer to clear than hyperglycemia—continue insulin even after glucose normalizes until ketones clear 3, 1
Electrolyte Management
Potassium Replacement—Most Critical
- If initial potassium <3.3 mEq/L, DELAY insulin therapy and aggressively replace potassium first to prevent fatal cardiac arrhythmias 1, 7
- Once potassium <5.5 mEq/L and adequate urine output confirmed, add 20-40 mEq/L potassium to IV fluids (2/3 KCl or potassium-acetate, 1/3 KPO₄) 3, 1
- Target serum potassium 4-5 mEq/L throughout treatment 1, 2
- Typical potassium deficit: 3-5 mEq/kg in DKA, 5-15 mEq/kg in HHS 2
- Critical mechanism: Insulin stimulates potassium movement into cells, potentially causing life-threatening hypokalemia, respiratory paralysis, and ventricular arrhythmias 7
Phosphate and Magnesium
- Consider phosphate replacement for severe hypophosphatemia, using 1/3 of potassium replacement as KPO₄ 3, 2
- Monitor and replace magnesium as needed—hypomagnesemia is common 5
Bicarbonate Therapy—Generally NOT Recommended
- Avoid sodium bicarbonate due to risks of worsening ketosis, hypokalemia, and cerebral edema 2, 5
- Consider bicarbonate ONLY if pH <6.9, or when pH <7.2 with serum bicarbonate <10 mEq/L pre- and post-intubation to prevent hemodynamic collapse 5
Monitoring Strategy
Frequency of Monitoring
- Check glucose, electrolytes, BUN, creatinine, osmolality, and venous pH every 2-4 hours during treatment 1, 2
- After initial diagnosis, venous pH and anion gap adequately monitor acidosis resolution—repeated arterial blood gases are unnecessary 1
- Monitor β-hydroxybutyrate every 2-4 hours alongside other parameters to track ketosis resolution 1
Resolution Criteria
- DKA resolved when: glucose <200 mg/dL, bicarbonate ≥18 mEq/L, venous pH >7.3, and anion gap ≤12 mEq/L 1, 2
- HHS resolved when: osmolality normalized, mental status improved, and patient clinically stable 3
Complications and Prevention
Cerebral Edema—Most Feared Complication
- Occurs in 0.7-1.0% of children with DKA, rare but frequently fatal 3
- Risk factors: Rapid overcorrection of hyperglycemia and hyperosmolarity, excessive fluid administration, failure to add dextrose when glucose reaches target 3, 5
- Prevention: Limit osmolality reduction to <3 mOsm/kg/H₂O per hour, avoid hypotonic fluids initially, monitor mental status closely 3, 1
- Characterized by deterioration in consciousness, lethargy, decreased arousal 3
Common Treatment Complications
- Hypoglycemia: From overzealous insulin treatment—add dextrose to fluids when glucose reaches 250 mg/dL (DKA) or 250-300 mg/dL (HHS) 3, 2
- Hypokalemia: From insulin administration and bicarbonate therapy—monitor and replace aggressively 3, 1
- Hyperchloremia and non-anion gap metabolic acidosis: From excessive saline use—transient and resolves spontaneously 3
- Hypoxemia and pulmonary edema: Rare, attributed to reduced colloid osmotic pressure; patients with widened alveolo-arteriolar oxygen gradient or pulmonary rales at higher risk 3
Airway Management in Critically Ill Patients
- Avoid BiPAP due to aspiration risk—use intubation and mechanical ventilation with careful acid-base and fluid status monitoring 5
- Consider bicarbonate if pH <7.2 pre-intubation to prevent metabolic acidosis and hemodynamic collapse from apnea during intubation 5
Special Considerations
Early Nutritional Support
- Initiate oral nutrition early once patient tolerates—reduces ICU and hospital length of stay 5
Balanced Crystalloid Solutions
- Balanced solutions (e.g., lactated Ringer's) show faster DKA resolution compared to normal saline in recent studies, though isotonic saline remains standard 5
British Guidelines Alternative Approach
- British guidelines recommend subcutaneous insulin glargine along with continuous IV regular insulin, showing faster DKA resolution and shorter hospital stays compared to IV insulin alone 5
Prevention of Recurrence
- Never discontinue insulin—common precipitant in urban populations due to economic reasons 3
- Educate on sick-day management: when to contact provider, supplemental short-acting insulin during illness, fever suppression, infection treatment, easily digestible liquid diet with carbohydrates and salt 3
- Monitor blood glucose and ketones when glucose >300 mg/dL 3